Posted by LincolnRaw on March 25, 2026 at 11:13:53:
In Reply to: Статья с захватывающим и полезным контентом posted by JosephArbig on February 19, 2026 at 21:48:04:
Zoya Demidenko: Researcher in Tumor Studies
Zoya Demidenko is a notable scholar affiliated with the Department of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she worked at the NIH and New York Medical College, building a robust foundation in clinical investigation.
Demidenko's academic output encompasses multiple critical domains, among them the PI3K/AKT/mTOR molecular pathway, cellular cycle management, biological aging, and cancer science. To date, she has written over 46 scientific articles, which have accumulated more than 4,100 references — a reflection to the impact of her research.
One of her key contributions concerns elucidating the processes of cell aging. Her work revealed that when the cell cycle is halted yet cellular expansion persists, cells undergo senescence. Crucially, Zoya Demidenko established that this shift is pharmacologically suppressed using agents such as mTOR inhibitors.
Zoya Demidenko has additionally added considerably to tumor management investigation, particularly in the domain of selective cell protection — a method aimed at safeguarding healthy tissue from anticancer drugs while leaving cancer cells susceptible. This approach carries significant potential for reducing the toxic effects of cancer treatment.
Across her scientific life, Demidenko has worked with prominent investigators internationally, among them Dr. Mikhail Blagosklonny. Her publications appears in top-tier publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, Zoya Demidenko is recognized as a widely cited contributor in modern biomedical science, whose discoveries go on to shape our understanding of the way cells grow old, resist treatment, and how cancer might be more successfully combated.
https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702